Your browser doesn't support javascript.
loading
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells.
Mangiapane, Laura Rosa; Nicotra, Annalisa; Turdo, Alice; Gaggianesi, Miriam; Bianca, Paola; Di Franco, Simone; Sardina, Davide Stefano; Veschi, Veronica; Signore, Michele; Beyes, Sven; Fagnocchi, Luca; Fiori, Micol Eleonora; Bongiorno, Maria Rita; Lo Iacono, Melania; Pillitteri, Irene; Ganduscio, Gloria; Gulotta, Gaspare; Medema, Jan Paul; Zippo, Alessio; Todaro, Matilde; De Maria, Ruggero; Stassi, Giorgio.
Afiliação
  • Mangiapane LR; Department of Surgical, Oncological and Stomatological Sciences, Università degli Studi di Palermo, Palermo, Italy.
  • Nicotra A; Department of Surgical, Oncological and Stomatological Sciences, Università degli Studi di Palermo, Palermo, Italy.
  • Turdo A; Department of Health Promotion Sciences, Internal Medicine and Medical Specialties, Università degli Studi di Palermo, Palermo, Italy.
  • Gaggianesi M; Department of Surgical, Oncological and Stomatological Sciences, Università degli Studi di Palermo, Palermo, Italy.
  • Bianca P; Department of Surgical, Oncological and Stomatological Sciences, Università degli Studi di Palermo, Palermo, Italy.
  • Di Franco S; Department of Surgical, Oncological and Stomatological Sciences, Università degli Studi di Palermo, Palermo, Italy.
  • Sardina DS; Department of Surgical, Oncological and Stomatological Sciences, Università degli Studi di Palermo, Palermo, Italy.
  • Veschi V; Department of Surgical, Oncological and Stomatological Sciences, Università degli Studi di Palermo, Palermo, Italy.
  • Signore M; Core Facilities, Istituto Superiore di Sanità, Roma, Italy.
  • Beyes S; Department of Cellular, Computational, and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
  • Fagnocchi L; Department of Cellular, Computational, and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
  • Fiori ME; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanita, Roma, Italy.
  • Bongiorno MR; Department of Health Promotion Sciences, Internal Medicine and Medical Specialties, Università degli Studi di Palermo, Palermo, Italy.
  • Lo Iacono M; Department of Surgical, Oncological and Stomatological Sciences, Università degli Studi di Palermo, Palermo, Italy.
  • Pillitteri I; Department of Surgical, Oncological and Stomatological Sciences, Università degli Studi di Palermo, Palermo, Italy.
  • Ganduscio G; Department of Surgical, Oncological and Stomatological Sciences, Università degli Studi di Palermo, Palermo, Italy.
  • Gulotta G; Department of Surgical, Oncological and Stomatological Sciences, Università degli Studi di Palermo, Palermo, Italy.
  • Medema JP; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, University of Amsterdam, Amsterdam, Noord-Holland, The Netherlands.
  • Zippo A; Oncode Institute, University of Amsterdam, Amsterdam, Noord-Holland, The Netherlands.
  • Todaro M; Department of Cellular, Computational, and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
  • De Maria R; Department of Health Promotion Sciences, Internal Medicine and Medical Specialties, Università degli Studi di Palermo, Palermo, Italy.
  • Stassi G; Institute of General Pathology, Universita Cattolica del Sacro Cuore Facolta di Medicina e Chirurgia, Roma, Italy giorgio.stassi@unipa.it ruggero.demaria@unicatt.it.
Gut ; 71(1): 119-128, 2022 01.
Article em En | MEDLINE | ID: mdl-33436496
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Receptor ErbB-2 / Fosfatidilinositol 3-Quinase / Inibidores de Fosfoinositídeo-3 Quinase Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Receptor ErbB-2 / Fosfatidilinositol 3-Quinase / Inibidores de Fosfoinositídeo-3 Quinase Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article